99 related articles for article (PubMed ID: 1548692)
1. A non-haemagglutinating form of Clostridium difficile toxin A.
Kamiya S; Borriello SP
J Med Microbiol; 1992 Mar; 36(3):190-7. PubMed ID: 1548692
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction.
Kamiya S; Reed PJ; Borriello SP
J Med Microbiol; 1989 Sep; 30(1):69-77. PubMed ID: 2778794
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterisation of intracellular toxin A of Clostridium difficile.
Meng XQ; Kamiya S; Yamakawa K; Ogura H; Nakamura S
J Med Microbiol; 1993 Jan; 38(1):69-73. PubMed ID: 8418298
[TBL] [Abstract][Full Text] [Related]
4. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related.
von Eichel-Streiber C; Harperath U; Bosse D; Hadding U
Microb Pathog; 1987 May; 2(5):307-18. PubMed ID: 2467163
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile.
Martinez RD; Wilkins TD
J Med Microbiol; 1992 Jan; 36(1):30-6. PubMed ID: 1370542
[TBL] [Abstract][Full Text] [Related]
6. Simplified purification method for Clostridium difficile toxin A.
Fu SW; Xue J; Zhang YL; Zhou DY
World J Gastroenterol; 2004 Sep; 10(18):2756-8. PubMed ID: 15309736
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on apoptosis induction of SMMC7721 and Vero cells by Clostridium difficile toxin A.
Zhao J; Wang D; Zhao H; Lin W
Ai Zheng; 2003 Jul; 22(7):719-24. PubMed ID: 12866963
[TBL] [Abstract][Full Text] [Related]
8. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin.
Krivan HC; Wilkins TD
Infect Immun; 1987 Aug; 55(8):1873-7. PubMed ID: 3112015
[TBL] [Abstract][Full Text] [Related]
9. Production of monoclonal antibody to Clostridium difficile toxin A which neutralizes enterotoxicity but not haemagglutination activity.
Kamiya S; Yamakawa K; Meng XQ; Ogura H; Nakamura S
FEMS Microbiol Lett; 1991 Jul; 65(3):311-5. PubMed ID: 1916231
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding.
Rolfe RD; Song W
J Med Microbiol; 1995 Jan; 42(1):10-9. PubMed ID: 7739018
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the physicochemical interactions between Clostridium difficile toxins and cholestyramine using liquid chromatography with post-column derivatization.
Palace GP; Lazari P; Norton K
Biochim Biophys Acta; 2001 Mar; 1546(1):171-84. PubMed ID: 11257520
[TBL] [Abstract][Full Text] [Related]
12. Isolation and purification of Aeromonas sobria cytotonic enterotoxin and beta-haemolysin.
Gosling PJ; Turnbull PC; Lightfoot NF; Pether JV; Lewis RJ
J Med Microbiol; 1993 Mar; 38(3):227-34. PubMed ID: 8384263
[TBL] [Abstract][Full Text] [Related]
13. Detection of Clostridium difficile Toxin A by immunoblotting.
Rautenberg P; Stender F; Ullmann U
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):29-42. PubMed ID: 3518293
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile toxin A and its effects on cells.
Fiorentini C; Thelestam M
Toxicon; 1991; 29(6):543-67. PubMed ID: 1926159
[TBL] [Abstract][Full Text] [Related]
15. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
Antunes A; Dupuy B
Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).
Martinez RD; Wilkins TD
Infect Immun; 1988 May; 56(5):1215-21. PubMed ID: 3128481
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
Torres JF
J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544
[TBL] [Abstract][Full Text] [Related]
18. Binding of Clostridium difficile toxins to human milk oligosaccharides.
El-Hawiet A; Kitova EN; Kitov PI; Eugenio L; Ng KK; Mulvey GL; Dingle TC; Szpacenko A; Armstrong GD; Klassen JS
Glycobiology; 2011 Sep; 21(9):1217-27. PubMed ID: 21610194
[TBL] [Abstract][Full Text] [Related]
19. Purification and properties of Clostridium difficile cytotoxin B.
Pothoulakis C; Barone LM; Ely R; Faris B; Clark ME; Franzblau C; LaMont JT
J Biol Chem; 1986 Jan; 261(3):1316-21. PubMed ID: 3944088
[TBL] [Abstract][Full Text] [Related]
20. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
Lyerly DM; Phelps CJ; Toth J; Wilkins TD
Infect Immun; 1986 Oct; 54(1):70-6. PubMed ID: 2428753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
